Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT

ABSTRACT:

SUBMITTER: Lahtinen A 

PROVIDER: S-EPMC12378959 | biostudies-literature | 2025 Jun

REPOSITORIES: biostudies-literature